SOX11 and leukemia: Figure 5b shows that the intensity of SOX11 antibody staining could readily separate the high expressors (REH and RCH-ACV) from the low expressors (NALM-6 and KOPN-8) in leukemia cell lines, suggesting that SOX11 antibodies could possibly be used as a biomarker in the future.